Zenflow

Company Overview

Zenflow, based in South San Francisco, CA, operates in the healthcare industry, specifically within the medical devices sub-sector. The company was founded out of the Stanford Byers Center for Biodesign and has a team of 18 members. Zenflow focuses on developing disease-modifying therapies for benign prostatic hyperplasia (BPH). The company's flagship product is the Zenflow Spring System, which provides symptom relief for BPH through a minimally invasive procedure.

Zenflow Spring System

The Zenflow Spring System is a small implant designed to provide quick and long-lasting relief from benign prostatic hyperplasia (BPH) symptoms. The device is delivered through a simple procedure performed in a urologist's office. Clinical studies have shown that most patients experience symptom relief and fully recover from the procedure within hours. The Zenflow Spring System has garnered attention at notable events such as the AUA and EAU 2023 Meetings and was featured in a Urology Times article for its promise in BPH treatment.

Clinical Trials and Research

Zenflow launched a pivotal clinical trial for the minimally invasive Spring® Treatment for enlarged prostate symptoms on October 4, 2021. The promising clinical study results were featured at the AUA 2021 Meeting. These trials and studies consistently demonstrate the efficacy and rapid recovery associated with the Zenflow Spring System, making it a notable innovation in BPH treatment.

Leadership and Recognition

Shreya Mehta, Zenflow's CTO and Founder, has been recognized as a Healthtech Leader of the Month by the UCSF Rosenman Institute. CEO Susan Stimson was featured in a DeviceTalks Podcast discussing Zenflow's contributions to urology treatment. The company has also been highlighted in various media outlets, including a Forbes article recognizing it as among 50 women-led startups excelling in tech, and a MedTech Stories Podcast with Shreya Mehta.

Accolades and Contributions

Zenflow participated in the Stanford Byers Center for Biodesign program, which has impacted over a million patients. In 2015, the company was a semi-finalist in the Medtech Innovator competition. Zenflow's innovative work and contributions to urology have been recognized in multiple industry forums and publications, establishing its role in advancing medical device technology for BPH treatment.

Report inaccurate information

Companies similar to Zenflow

Imperative Care accelerates the development of life-changing technologies for stroke and vascular diseases, offering interventional solutions and advancing innovative treatments through its Vascular business and subsidiaries like Kandu Health and Telos Health.

UroDev Medical, formerly known as Spinal Singularity, is a healthcare company based in Minneapolis, MN, specializing in medical devices for urinary retention, notably the IntelliFlow Bladder Management System.

United Medical Systems provides high-quality shared healthcare service programs for urology, offering advanced technologies and cost-efficient solutions, including non-invasive treatments for kidney stones and prostate cancer detection.

Rx Redefined is a company that provides full-service DMEPOS supply and delivery through physician personal performance, trusted in over 400 clinics across the U.S., and has raised $10 million in funding.

Vena Medical, based in Kitchener, ON, Canada, is a medical device company specializing in innovative healthcare technologies, with significant achievements including FDA clearance and Health Canada approval.

Pulmonx is a medical technology company specializing in minimally invasive treatments for severe emphysema, notably through its FDA-approved Zephyr Valve. The company also offers the StratX Lung Analysis Platform and the Chartis Pulmonary Assessment System.

Volt Health, based in Mountain View, CA, developed electrostimulation wearables aimed at treating conditions such as incontinence and migraines, targeting a significant market within the healthcare and medical devices industry.

Urologix develops and markets minimally invasive therapies for Benign Prostatic Hyperplasia (BPH), offering treatments like Cooled ThermoTherapy and Prostiva RF Therapy that allow patients to return home the same day.

Second Heart Assist, based in Salt Lake City, Utah, develops innovative circulatory assist devices, including the 'Whisper' catheter-based pump and 'Freedom' wireless implant, aimed at enhancing heart and renal function.